{
  "id": 20190808,
  "title": "STAT+: FDA rejects lung cancer treatment ivonescimab from Summit Therapeutics",
  "url": "https://urgent.news/2026/11/15/stat-fda-rejects-lung-cancer-treatment-ivonescimab-from-summit",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-15T15:05:15.000Z",
  "source": {
    "name": "STAT News",
    "slug": "stat-news",
    "url": "https://www.statnews.com/2026/11/15/fda-rejects-ivonescimab-lung-cancer-treatment-summit-therapeutics/"
  },
  "original_language": "en",
  "account": null,
  "summary": "The FDA has rejected ivonescimab, a treatment for a type of lung cancer developed by U.S. biotech Summit Therapeutics and the Chinese drugmaker Akeso.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Endpoints News",
        "title": "FDA rejects Summit, Akeso's ivonescimab in narrow lung cancer setting",
        "url": "https://urgent.news/2026/11/15/fda-rejects-summit-akesos-ivonescimab-in-narrow-lung-cancer-setting",
        "published": "2026-11-15T12:56:23.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}